Insidious reintroduction of wild poliovirus into israel, 2013

Eurosurveillance

Volumn 18, Issue 38, 2013, Pages

  Anis, E ^a,b   Kopel, E ^a   Singer, S R ^a   Kaliner, E ^a   Moerman, L ^a   Moran Gilad, J ^a,c   Sofer, D ^a,d   Manor, Y ^a,d   Shulman, L M ^a,d   Mendelson, E ^a,d   Gdalevich, M ^a,c   Lev, B ^a   Gamzu, R ^a,d   Grotto, I ^a,c  

^a MINISTRY OF HEALTH   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE;

ARTICLE; ASEPTIC MENINGITIS; DISEASE SURVEILLANCE; ENVIRONMENTAL SANITATION; FLACCID PARALYSIS; HEALTH PROGRAM; HUMAN; HYGIENE; IMMUNIZATION; INCIDENCE; INFECTION CONTROL; ISRAEL; PERSONAL HYGIENE; POLIOMYELITIS; POLIOMYELITIS VIRUS; REAL TIME POLYMERASE CHAIN REACTION; SEWAGE DISPOSAL; VACCINATION; VIRUS DETECTION;

EID: 84884619903     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2013.18.38.20586     Document Type: Article

References (23)

1. Swartz TA. The epidemiology of polio in Israel. An historical perspective. Israel Center for Disease Control (ICDC), Ministry of Health; Tel Aviv: Nov 2008. Publication 317. Available from: http://www.old.health.gov.il/Download/pages/Polio_inIsrae251109l.pdf
2. Yekutiel P, Levinger EL, Muhsam HV, Yekutiel MP. Poliomyelitis outbreak in Israel, 1950-1. Bull World Health Organ. 1955;12(4):651-676. PMid:14379003. PMCid:PMC2542293.
3. Slater PE, Orenstein WA, Morag A, Avni A, Handsher R, Green MS, et al. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries. Lancet. 1990;335(8699):1192-1195; discussion 1196-8. http://dx.doi.org/10.1016/0140-6736(90)92705-M
4. Shulman LM, Handsher R, Yang CF, Yang SJ, Manor J, Vonsover A, et al. Resolution of the pathways of poliovirus type 1 transmission during an outbreak. J Clin Microbiol. 2000;38(3):945-952. PMid:10698978. PMCid:PMC86309.
5. World Health Organization (WHO). WHO vaccine-preventable diseases: monitoring system. 2013 global summary. Geneva: WHO. [Accessed 1 Sep 2013]. Available from: http://apps.who.int/immunization_monitoring/globalsummary/countries?countrycriteria%5Bcountry%5D%5B%5D=ISR
6. World Health Organization (WHO). Polio laboratory manual. 4th ed. Geneva: WHO; 2004. WHO/IVB/04.10. Available from: http://www.who.int/vaccines/en/poliolab/WHO-Polio-Manual-9.pdf
7. Manor Y, Blomqvist S, Sofer D, Alfandari J, Halmut T, Abramovitz B, et al. Advanced environmental surveillance and molecular analyses indicate separate importations rather than endemic circulation of wild type 1 poliovirus in Gaza district in 2002. Appl Environ Microbiol. 2007;73(18):5954-5958. http://dx.doi.org/10.1128/AEM.02537-06. PMid:17660306. PMCid:PMC2074904.
8. Kilpatrick DR, Yang CF, Ching K, Vincent A, Iber J, Campagnoli R, et al. Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J Clin Microbiol. 2009;47(6):1939-1941. http://dx.doi.org/10.1128/JCM.00702-09. PMid:19386844. PMCid:PMC2691077.
9. Kilpatrick DR, Iber JC, Chen Q, Ching K, Yang SJ, De L, et al. Poliovirus serotype-specific VP1 sequencing primers. J Virol Methods. 2011;174(1-2):128-130. http://dx.doi.org/10.1016/j.jviromet.2011.03.020. PMid:21440569.
10. ProMED-mail. Poliomyelitis - worldwide (01): Egypt ex Pakistan, Niger. Archive Number 20130122.1509210. 22 Jan 2013. Available from: http://www.promedmail.org/direct.php?id=20130122.1509210
11. The Knesset Research and Information Center. [The management of infiltrators from the Egyptian border]. 26 May 2010. [Hebrew]. Available from: http://www.knesset.gov.il/mmm/data/pdf/m02524.pdf
12. Ministry of Health (MoH). Supplemental polio vaccination campaign. "Two Drops" - the national supplementary immunisation activity official website. Jerusalem: MoH. [Accessed 1 Sep 2013]. Available from: http://www.health.gov.il/English/Topics/Vaccination/two_drops/Pages/default.aspx
13. World Health Organization (WHO). Guidelines on responding to the detection of wild poliovirus in the WHO European Region. Copenhagen: WHO; 2007. Available from: http://www.euro.who.int/__data/assets/pdf_file/0008/86498/E91123.pdf
14. World Health Organization (WHO). WHO package insert. Polio Sabin™ One and Three (oral). WHO model insert (June 09). GlaxoSmithKline Biologicals. Bivalent Oral Poliomyelitis Vaccine Types 1 and 3 (bOPV). Geneva: WHO. [Accessed 1 Sep 2013]. Available from: http://www.who.int/immunization_standards/vaccine_quality/OPV_bivalent_GSK_WHO_package_insert_text_english.pdf
15. Sutter RW, John TJ, Jain H, Agarkhedkar S, Ramanan PV, Verma H, et al. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial. Lancet. 2010;376(9753):1682-1688. http://dx.doi.org/10.1016/S0140-6736(10)61230-5
16. Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog. 2012;8(4):e1002599. http://dx.doi.org/10.1371/journal.ppat.1002599. PMid:22532797. PMCid:PMC3330118.
17. Swartz TA, Green MS, Handscher R, Sofer D, Cohen-Dar M, Shohat T, et al. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel. Vaccine. 2008;26(8):1083-1090. http://dx.doi.org/10.1016/j.vaccine.2007.12.021. PMid:18241962.
18. World Health Organization (WHO). Scientific evidence in support of: Note for the record: 5th meeting of the SAGE Working Group, World Health Organization, Geneva, September 3-4, 2012. Geneva: WHO; 2012. Available from: http://www.who.int/immunization/sage/meetings/2012/november/3__SAGE_WG_Scientific_Evidence22Oct2012.pdf
19. Oostvogel PM, van Wijngaarden JK, van der Avoort HG, Mulders MN, Conyn-van Spaendonck MA, Rümke HC, et al. Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992-93. Lancet. 1994;344(8923):665-670. http://dx.doi.org/10.1016/S0140-6736(94)92091-5
20. Hovi T, Cantell K, Huovilainen A, Kinnunen E, Kuronen T, Lapinleimu K, et al. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet. 1986;1(8495):1427-1432. http://dx.doi.org/10.1016/S0140-6736(86)91566-7
21. Pöyry T, Kinnunen L, Kapsenberg J, Kew O, Hovi T. Type 3 poliovirus/Finland/1984 is genetically related to common Mediterranean strains. J Gen Virol. 1990;71(Pt 11):2535-2541. http://dx.doi.org/10.1099/0022-1317-71-11-2535. PMid:1701473.
22. Simonen ML, Roivainen M, Iber J, Burns C, Hovi T. Outbreak of poliomyelitis in Finland in 1984-85 - Re-analysis of viral sequences using the current standard approach. Virus Res. 2010;147(1):91-97. http://dx.doi.org/10.1016/j.virusres.2009.10.012. PMid:19883702.
23. Tulchinsky TH. Polio eradication: end-stage challenges. Bull World Health Organ. 2005;83(2):160. PMid:15744411. PMCid:PMC2623815.